Resolution of historically discordant Ames test negative/rodent carcinogenicity positive <i>N</i>-nitrosamines using a sensitive, OECD-aligned design
Dean N Thomas(Age UK), Anthony M Lynch(Age UK), Angela White(GlaxoSmithKline (United Kingdom)), Jonathan Howe(GlaxoSmithKline (United Kingdom)), James Harvey(GlaxoSmithKline (United Kingdom)), Mark Burman(Age UK), Ruby A Buckley(Age UK), Benjamin Jeffries(Age UK), Abbie N Williams(Age UK), Danielle S G Harte(Age UK), Anne-Sophie Bretonnet(Age UK), John W. Wills(Age UK)
Cited by 7
Related Papers
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010|106
Follow‐up actions from positive results of in vitro genetic toxicity testing
|Environmental and Molecular Mutagenesis|2010|60
Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters
|Mutagenesis|2023|56
Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip
|Cell stem cell|2024|29
Qualification of impurities based on metabolite data
|Regulatory Toxicology and Pharmacology|2019|20